Search

1222498
1230819
1201004
1195994
393884
ScimathUS
The South African Tuberculosis Vaccine Initiative will be offering a limited number of bursaries to cover the Registration Fees associated with the SciMathUS Program, a university preparation program which is offered by the Stellenbosch University...
2018 Tb under the Spotlight Science Engagement
The “TB Under the Spotlight Science Engagement” programme was conceptualised and presented by South African Tuberculosis Vaccine Initiative (SATVI) with scientists from the Division of Molecular Biology and Human Genetics at Stellenbosch University...
Community Engagement
Lienkie's Lungs TB Awareness Drama: SATVI collaborated with the UCT Drama Department and the Mothertongue Community project in developing "Lienkie se Longe", a drama to raise awareness about TB. The drama was performed at community clinics and...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
Carina's Choice: SATVI collaborated with UCT Drama Department and Worcester Secondary School in developing this play which was performed by learners from Worcester Secondary School at 8 local high schools reaching approximately 8 000 adolescents in...

News

Monday, 17 December 2018
11 December 2018 Latest Research Building capacity for advances in TB research

Professor Mark Hatherill has co-authored a journal article titled "Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting" appearing in the Tuberculosis (Edinb) Journal.

Publication Date:
Tue, 11 Dec 2018 - 14:30
6 December 2018 Latest Research Metabolite changes in blood predict the onset of TB

Professor Tom Scriba has co-authored a paper titled: “Metabolite changes in blood predict the onset of tuberculosis” in the  Nature Journal.

Publication Date:
Fri, 07 Dec 2018 - 14:00
1 December 2018 Latest Research Safety and Immunogenicity of early Bacillus Calmette-Guerin (BCG) vaccination in infants who are preterm and/or have low birth weights:

Prof Mark Hatherill has co-authored a journal article titled: "Safety and Immunogenicity of early Bacillus Calmette-Guerin (BCG) vaccination in infants who are preterm and/or have low birth weights: A systematic review and meta-analysis" appearing in the Journal of American Medical Association (JAMA).

Publication Date:
Tue, 04 Dec 2018 - 14:00
15 November 2018 Research: Commentary WHO Preferred Product Preferences for TB Vaccines

SATVI Director Professor Mark Hatherill has co-authored a commentary titled "WHO preferred product characteristics for new vaccines against tuberculosis" appearing in The Lancet journal.

Publication Date:
Thu, 15 Nov 2018 - 11:30

Pages